Superantigen production by Staphylococcus aureus in psoriasis

Dermatology

Volumn 196, Issue 2, 1998, Pages 194-198

  Sayama, Koji ^a   Midorikawa, K ^a   Hanakawa, Y ^a   Sugai, M ^b   Hashimoto, K ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Exfoliative toxin; Polymerase chain reaction; Staphylococcal enterotoxin B; Toxic shock syndrome toxin 1; Western blot

Indexed keywords

BACTERIAL ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; SKIN; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; THROAT;

ADOLESCENT; ADULT; AGED; BACTERIAL TOXINS; BLOTTING, WESTERN; ENTEROTOXINS; EXFOLIATINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARYNX; POLYMERASE CHAIN REACTION; PSORIASIS; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 0031910364     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017898     Document Type: Article

References (25)

1. Valdimarsson H, Baker BS, Jonsddottir I, Powles A, Fry L: Psoriasis: A T-cell-mediated autoimmune disease induced by Staphylococcus superantigen? Immunol Today 1995;16: 145-149.
2. Prinz JC, Grob B, Vollmer S, Trommler P, Strobel I, Meurer M, Plewig G: T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vivo via secreted products. Eur J Immunol 1994;24:593-598.
3. Prinz J, Braun-Falco O, Meurer M, Daddona P, Reiter C, Rieber P, Riethmuller G: Chimeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis. Lancet 1991;338: 320-321.
4. Nicolas JF, Chamchick N, Thivolet J, Windenes J, Morel P, Revillard JP: CD4 antibody treatment of severe psoriasis. Lancet 1991; 338:321.
5. Ellis CN, Gorsulowsky DC, Hamilton TA, Billings J, Brown M, Headington K, Cooper K, Baadsgaard O, Duell E, Annesley T: Cyclosporin improves psoriasis in a double-blind study. JAMA 1986;256:3110-3116.
6. Kotzin B, Leung D, Kappler J, Marrack P: Superantigens and their potential role in human diseases. Adv Immunol 1993;54:99-165.
7. Tokura Y, Yagi J, O'Malley M, Lewis JM, Takigawa M, Edelson RL, Tigelaar E: Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994;102: 31-38.
8. Leung DYM, Walsh P, Giorno R, Norris DA: A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 1993; 100:225-228.
9. Leung DYM, Travers JB, Norris DA: The role of superantigens in skin disease. J Invest Dermatol 1995;105:37S-42S.
10. Whyte JJ, Baughman PD: Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964;89:350-356.
11. Marples RR, Heaton CL, Kligman AM: Staphylococcus aureus in psoriasis. Arch Dermatol 1973;107:568-570.
12. Lewis HM, Baker BS, Bokth S, Powles AV, Garioch JJ, Valdimarsson H, Fry L: Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993;129:514-520.
13. Chang JCC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Caralli LL, Kurland HH, Karasek MA, Wilkinson DI, Carlo DJ, Brostoff SW: CD8+ T cell in psoriatic lesions preferentially T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc Natl Acad Sci USA 1994;91:9282-9286.
14. Leung DYM, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, Kazemi LV, Kim MH, Trumble AE, Kotb M, Schlievert PM: Evidence for streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995;96:2106-2112.
15. Bour H, Demidem A, Garrigue J-L, Krasteva M, Schmitt D, Claudy A, Nicolas J-F: In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis. Acta Derm Venereol (Stockh) 1995; 75:218-221.
16. Baker BS, Bokth S, Powles A, Garioch JJ, Lewis H, Valdimarsson H, Fry L: Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993;128:493-499.
17. Yokote R, Tokura Y, Furukawa F, Takigawa M: Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis. Arch Dermatol Res 1995;287:443-447.
18. Boehncke E-H, Dressel D, Zollner TM, Kaufmann R: Pulling the trigger on psoriasis. Nature 1996;376:777.
19. Sugai M, Inoue S, Hino T, Kuwabara M, Hong Y-M, Miyake Y, Suginaka H: Purification of staphylococcal exfoliative toxin by high pressure liquid chromatography. Zentralbl Bakteriol 1990;273:5-11.
20. Sakurai S, Suzuki H, Machida K: Rapid identification by polymerase chain reaction of staphylococcal exfoliative toxin serotype A and B genes. Microbiol Immunol 1995;39:379-386.
21. Ignatov KB, Chistyakova LG, Shemchukova OB, Gorodetskaya SB, Kiselev VI: Cloning of the Staphylococcus aureus enterotoxin B gene obtained by the polymerase chain reaction, and its expression in Escherichia coli cells. Bioorganicheskaya Khimiya 1993;19:75-80.
22. Johnson WM, Tyler SD, Ewan EP, Ashton FE, Pollard DR, Rozee KR: Detection of gene for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol 1991;29:426-430.
23. Boehncke W-H, Dressel D, Manfras B, Zollner TM, Wettstein A, Bohm BO, Sterry W: T-cell receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated Vβ regions. J Invest Dermatol 1995;104:725-728.
24. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O: Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
25. Saloga J, Leung DYM, Reardon C, Giorno RC, Born W, Gelfand W: Cutaneous exposure to the superantigen Staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response. J Invest Dermatol 1996;106:982-988.